BIOCATALYST 4 DEVELOPMENT - Key Persons
Alfonso Ruiz is a QA consultant with an expertise in Quality Systems, QC Lab Controls, Manufacturing Processes, Process Validation, Supplier Quality, Incoming Inspection, CAPA Management, Complaint System, Deviation Management, QC and Manufacturing Investigations, Product Transfer Process, Regulatory Compliance and Production Management.
Diane Kalina has more than 40 years experience as a biotech/pharma executive with proven skills in strategic alliances, marketing, strategy development, financing and managing start-up biotech companies.
Job Titles:
- Business Manager
- Financial Analyst
Joseph Cuatico is a business manager, financial analyst and entrepreneur. Joseph's previous experience is a blend of financial analysis, technology implementation and operations and he has worked in a variety of industries including biopharma.
Job Titles:
- BUSINESS & DRUG DEVELOPMENT SPECIALIST
Patricia Griffin has more than 30 years of international experience, including establishing and managing strategic alliances, evaluating in-licensing opportunities and leading a variety of drug development programs for biologics, small molecules and drug conjugates.
Patricia was previously Managing Director and CEO and co-founder of PDC Biotech GmbH, an Austrian biotech company which successfully raised funding in Europe and advanced an early preclinical-stage drug candidate through cGMP manufacturing to clinical proof-of-concept. Other positions include Vice President, Business Development at GlycoDesign Inc., a Canadian biotechnology company, where she led commercialization efforts for the company's cancer, vascular and inflammation programs and established and managed international strategic partnerships. As Director of International Product Development at Ferring based in Paris, Patricia led multi-disciplinary teams to successfully complete the development program (including scale-up of the peptide to support commercial needs) for two novel obstetrics products and managed the company's strategic alliance with a major US pharmaceutical company. As an independent consultant, she conducted detailed assessments of potential in-licensing opportunities for pharmaceutical companies and created business plans and product development plans for various biotech companies.
Wendy Hill has over 30 years of experience in early nonclinical and clinical development and regulatory affairs in a variety of therapeutic areas including cancer, inflammation, wound care, infectious and cardiovascular disease.